{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:37Z","timestamp":1793317897728,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejphar.2024.176712","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:39:14Z","timestamp":1718764754000},"page":"176712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Dapagliflozin: A sodium\u2013glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling"],"prefix":"10.1016","volume":"978","author":[{"given":"Ge","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5102-5238","authenticated-orcid":false,"given":"Xinying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailian","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176712_bib1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176712_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","article-title":"Inflammation and fibrosis in murine models of heart failure","volume":"114","author":"Bacmeister","year":"2019","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176712_bib3","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1001\/jama.2020.23700","article-title":"Atrial fibrillation","volume":"325","author":"Baman","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2024.176712_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12933-019-0928-8","article-title":"Atrial fibrillation and its arrhythmogenesis associated with insulin resistance","volume":"18","author":"Chan","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2024.176712_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-022-01480-1","article-title":"Direct cardiac effects of SGLT2 inhibitors","volume":"21","author":"Chen","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2024.176712_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","article-title":"A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation","volume":"133","author":"Erickson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.176712_bib7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2024.176712_bib8","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/Glucose cotransporter inhibitor Canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2024.176712_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00395-020-00834-8","article-title":"Hyperglycemia regulates cardiac K(+) channels via O-GlcNAc-CaMKII and NOX2-ROS-PKC pathways","volume":"115","author":"Hegyi","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176712_bib10","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology: implications for management","volume":"124","author":"Iwasaki","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176712_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.phrs.2017.10.007","article-title":"Atrial fibrillation and arterial hypertension","volume":"128","author":"Kallistratos","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.176712_bib12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium signaling and cardiac arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176712_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1042\/CS20210094","article-title":"Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice","volume":"135","author":"Miyata","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejphar.2024.176712_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2016.10.006","article-title":"CaMKII as a target for arrhythmia suppression","volume":"176","author":"Mustroph","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2024.176712_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-018-0749-1","article-title":"Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice","volume":"17","author":"Nasiri-Ansari","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2024.176712_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCRESAHA.121.319718","article-title":"Effects of atrial fibrillation on the human ventricle","volume":"130","author":"Pabel","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176712_bib17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176712_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12933-022-01506-8","article-title":"Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry","volume":"21","author":"Paolisso","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2024.176712_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2024.176712_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/europace\/eun193","article-title":"Role of potassium currents in cardiac arrhythmias","volume":"10","author":"Ravens","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.ejphar.2024.176712_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pharmtox-051421-111814","article-title":"CaMKII as a therapeutic target in cardiovascular disease","volume":"63","author":"Reyes Gaido","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2024.176712_bib22","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2337\/dc22-0294","article-title":"Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: the FIDELITY analysis","volume":"45","author":"Rossing","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2024.176712_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrcardio.2009.44","article-title":"Sodium channel mutations and arrhythmias","volume":"6","author":"Ruan","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176712_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","article-title":"Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus","volume":"16","author":"Scheen","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176712_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/physrev.00022.2013","article-title":"Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia","volume":"94","author":"Schmitt","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2024.176712_bib26","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1172\/JCI57833","article-title":"Oxidized CaMKII causes cardiac sinus node dysfunction in mice","volume":"121","author":"Swaminathan","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.176712_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2024.176712_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1152\/physrev.00024.2019","article-title":"Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior","volume":"101","author":"Varr\u00f3","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2024.176712_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCEP.108.842799","article-title":"Ca\/calmodulin kinase II differentially modulates potassium currents","volume":"2","author":"Wagner","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ejphar.2024.176712_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.968014","article-title":"Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX\/CaMKII mechanism","volume":"9","author":"Xu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejphar.2024.176712_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.048121","article-title":"Cardiac pressure overload decreases ETV1 expression in the left atrium, contributing to atrial electrical and structural remodeling","volume":"143","author":"Yamaguchi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176712_bib32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.122.322259","article-title":"Dectin-1 acts as a non-classical receptor of Ang II to induce cardiac remodeling","volume":"132","author":"Ye","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176712_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.176712_bib34","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of Dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176712_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-021-01312-8","article-title":"Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGF\u03b21\/Smad signaling","volume":"20","author":"Zhang","year":"2021","journal-title":"Cardiovasc. Diabetol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400400X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400400X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T16:10:27Z","timestamp":1721664627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992400400X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"alternative-id":["S001429992400400X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176712","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin: A sodium\u2013glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176712"}}